InvestorsHub Logo
Followers 7
Posts 577
Boards Moderated 0
Alias Born 08/18/2015

Re: None

Thursday, 09/03/2015 7:04:43 AM

Thursday, September 03, 2015 7:04:43 AM

Post# of 18784
What makes this company A Strong Buy

FIRST:
http://www.cancer.org/cancer/endometrialcancer/detailedguide/endometrial-uterine-cancer-what-is-endometrial-cancer

Now the only cure is surgery and it invloves many risks e.g. if the patient is under 30 and wants to ever have children.. This drug is the only real cure and is huge thing. If we get FDA approval we will probably be $60-$150 stock.

COMPANY FACTS:
#Phase 3 trial in endometrial cancer: News estimated to come in 1 month from now
#Phase 3 trial for the evaluation of AGHD: Patients recruited soon.
#Commercial activities in order to generate significant revenue and also reduce cashburn
#New clinical trials possibly coming/Pipe updates possibly coming soon
#No debt
#CPS around 0.20-0.24 (estimate)

Try to find another Biotech with this strong Pipe etc. trading under .10?!

***Strong Buy***
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEZS News